1. Home
  2. ALTI vs ALDX Comparison

ALTI vs ALDX Comparison

Compare ALTI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • ALDX
  • Stock Information
  • Founded
  • ALTI 2020
  • ALDX 2004
  • Country
  • ALTI United States
  • ALDX United States
  • Employees
  • ALTI N/A
  • ALDX N/A
  • Industry
  • ALTI Investment Managers
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTI Finance
  • ALDX Health Care
  • Exchange
  • ALTI Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • ALTI 283.9M
  • ALDX 304.9M
  • IPO Year
  • ALTI N/A
  • ALDX 2014
  • Fundamental
  • Price
  • ALTI $2.66
  • ALDX $6.91
  • Analyst Decision
  • ALTI
  • ALDX Strong Buy
  • Analyst Count
  • ALTI 0
  • ALDX 2
  • Target Price
  • ALTI N/A
  • ALDX $10.00
  • AVG Volume (30 Days)
  • ALTI 116.9K
  • ALDX 636.8K
  • Earning Date
  • ALTI 05-09-2025
  • ALDX 05-01-2025
  • Dividend Yield
  • ALTI N/A
  • ALDX N/A
  • EPS Growth
  • ALTI N/A
  • ALDX N/A
  • EPS
  • ALTI N/A
  • ALDX N/A
  • Revenue
  • ALTI $206,935,000.00
  • ALDX N/A
  • Revenue This Year
  • ALTI N/A
  • ALDX N/A
  • Revenue Next Year
  • ALTI $11.83
  • ALDX N/A
  • P/E Ratio
  • ALTI N/A
  • ALDX N/A
  • Revenue Growth
  • ALTI N/A
  • ALDX N/A
  • 52 Week Low
  • ALTI $2.40
  • ALDX $2.71
  • 52 Week High
  • ALTI $6.99
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 22.44
  • ALDX 61.80
  • Support Level
  • ALTI $3.33
  • ALDX $6.79
  • Resistance Level
  • ALTI $3.64
  • ALDX $7.20
  • Average True Range (ATR)
  • ALTI 0.27
  • ALDX 0.56
  • MACD
  • ALTI -0.05
  • ALDX 0.03
  • Stochastic Oscillator
  • ALTI 20.97
  • ALDX 88.02

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Share on Social Networks: